Robot maker · registered
ForSight Robotics
JASPER platform (formerly ORYOM): 14-DOF ophthalmic microsurgical robot integrating AI-based algorithms, advanced computer vision, miniaturized mechanics, and stereoscopic imaging; designed for complete cataract surgery and widespread eye diseases; motion scaling and surgeon-assist throughout procedure; active US clinical trial (NCT07468409); achieved world's first fully robot-assisted cataract surgery in a human patient (April 2026).
Company overview
Identity and operating footprint
Robot models
Specifications remain vendor-claimed
JASPER Platform
- 14-DOF microsurgical robot; AI-based algorithms, advanced computer vision, and miniaturized mechanics engineered for precise, consistent ophthalmic procedures
Vendor-stated degrees of freedom and autonomy approach for the JASPER (formerly ORYOM) ophthalmic surgical platform
Claim source - Performed world's first fully robot-assisted cataract surgery in a human patient without general anesthesia (April 2026, clinical study setting)
Independently reported first-in-human milestone for the JASPER platform, confirming hardware capability in an active clinical study
Claim source
Deployment log
Announced and cited only
Funding history
Publicly announced rounds
Series B
Adani Group, Dr. Fred Moll, Eclipse, Reiya Ventures
Round sourceSeries A
Adani Group, Eclipse Ventures, Ljungstrom family office, Mithril Capital Management, Precision Capital, Provenio Capital, Reiya Ventures
Round sourceSeed
Eclipse Ventures, Mithril Capital Management
Round sourceHiring signal
Public job board · 2026-07-11
Hiring is an operating signal, not deployment evidence. Roles are refreshed from the company’s public careers system.
Company timeline
Milestones and announcements
Source ledger
7 unique public sources